First Time Loading...
C

CTC Bio Inc
KOSDAQ:060590

Watchlist Manager
CTC Bio Inc
KOSDAQ:060590
Watchlist
Price: 7 960 KRW 0.13% Market Closed
Updated: May 29, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

135.8B
-1%
Revenue
Growth Rates:
1 Year
-10%
3 Years
+3%
5 Years
+3%
7 Years
+7%
10 Years
+9%
-5.1B
-11%
Operating Income
Growth Rates:
1 Year
+20%
3 Years
-25%
5 Years
+45%
7 Years
+9%
10 Years
-
-14.2B
+9%
Net Income
Growth Rates:
1 Year
-728%
3 Years
+17%
5 Years
-36%
7 Years
-200%
10 Years
-1 692%

Earnings Waterfall
CTC Bio Inc

Revenue
135.8B KRW
Cost of Revenue
-90.6B KRW
Gross Profit
45.2B KRW
Operating Expenses
-50.3B KRW
Operating Income
-5.1B KRW
Other Expenses
-9.1B KRW
Net Income
-14.2B KRW

Income Statement
CTC Bio Inc

Rotate your device to view
Income Statement
Currency: KRW
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
124 541
N/A
125 846
+1%
122 697
-3%
121 855
-1%
123 169
+1%
120 961
-2%
118 321
-2%
118 991
+1%
115 296
-3%
116 796
+1%
124 483
+7%
123 146
-1%
126 689
+3%
129 176
+2%
127 007
-2%
130 559
+3%
135 375
+4%
136 359
+1%
136 756
+0%
138 400
+1%
132 269
-4%
133 566
+1%
134 619
+1%
136 124
+1%
136 645
+0%
135 041
-1%
135 117
+0%
130 032
-4%
132 378
+2%
130 642
-1%
130 017
0%
140 318
+8%
157 384
+12%
167 235
+6%
172 996
+3%
165 206
-5%
150 208
-9%
145 562
-3%
138 214
-5%
137 878
0%
135 825
-1%
Gross Profit
Cost of Revenue
(91 866)
(91 571)
(88 741)
(85 247)
(84 318)
(82 407)
(83 018)
(83 186)
(83 020)
(85 929)
(88 211)
(90 770)
(94 485)
(95 851)
(98 042)
(100 621)
(101 816)
(102 954)
(100 390)
(101 491)
(100 506)
(102 498)
(106 483)
(109 494)
(110 585)
(109 399)
(109 220)
(103 402)
(103 306)
(101 360)
(99 689)
(106 821)
(113 408)
(116 882)
(118 196)
(110 655)
(103 401)
(99 864)
(94 772)
(94 812)
(90 591)
Gross Profit
32 676
N/A
34 276
+5%
33 957
-1%
36 607
+8%
38 852
+6%
38 555
-1%
35 303
-8%
35 805
+1%
32 275
-10%
30 866
-4%
36 273
+18%
32 376
-11%
32 205
-1%
33 326
+3%
28 965
-13%
29 938
+3%
33 557
+12%
33 403
0%
36 364
+9%
36 909
+1%
31 764
-14%
31 069
-2%
28 137
-9%
26 629
-5%
26 060
-2%
25 642
-2%
25 897
+1%
26 629
+3%
29 071
+9%
29 280
+1%
30 327
+4%
33 497
+10%
43 976
+31%
50 353
+15%
54 799
+9%
54 551
0%
46 808
-14%
45 698
-2%
43 442
-5%
43 066
-1%
45 234
+5%
Operating Income
Operating Expenses
(32 487)
(33 473)
(34 953)
(36 497)
(36 936)
(35 828)
(34 917)
(32 842)
(31 440)
(31 552)
(33 562)
(35 011)
(37 748)
(38 943)
(40 699)
(43 995)
(43 785)
(44 128)
(42 829)
(42 766)
(41 049)
(40 630)
(37 636)
(30 650)
(31 938)
(30 496)
(31 298)
(32 507)
(33 127)
(33 638)
(37 122)
(36 435)
(38 741)
(40 198)
(42 509)
(43 321)
(53 118)
(45 876)
(54 880)
(47 645)
(50 295)
Selling, General & Administrative
(27 683)
(27 985)
(28 452)
(29 955)
(30 289)
(29 700)
(29 002)
(27 451)
(26 391)
(26 646)
(26 994)
(27 040)
(29 163)
(30 322)
(31 753)
(36 671)
(36 166)
(36 513)
(37 010)
(36 614)
(33 590)
(33 385)
(31 317)
(26 800)
(28 432)
(27 043)
(27 376)
(27 444)
(27 479)
(28 610)
(30 588)
(32 060)
(34 092)
(35 766)
(36 957)
(39 544)
(41 090)
(42 226)
(42 680)
(43 623)
(45 786)
Research & Development
(4 187)
(4 871)
(5 837)
(5 952)
(6 094)
(5 574)
(5 360)
(4 930)
(4 291)
(4 128)
(5 709)
(7 365)
(7 695)
(7 447)
(7 578)
(5 777)
(5 768)
(6 056)
(4 277)
(4 584)
(4 227)
(3 843)
(2 976)
(2 404)
(2 155)
(2 371)
(2 894)
(3 907)
(3 865)
(3 752)
(3 951)
(3 090)
(3 330)
(3 171)
(2 932)
(2 414)
(2 227)
(2 202)
(2 250)
(2 639)
(3 177)
Depreciation & Amortization
(618)
(617)
(586)
(589)
(569)
(554)
(555)
(461)
(425)
(399)
(479)
(607)
(893)
(1 176)
(1 368)
(1 547)
(1 552)
(1 556)
(1 540)
(1 568)
(1 539)
(1 700)
(1 650)
(1 445)
(1 351)
(1 083)
(1 028)
(1 155)
(1 166)
(1 275)
(1 300)
(1 284)
(1 319)
(1 262)
(1 282)
(1 363)
(1 370)
(1 448)
(1 435)
(1 383)
(1 332)
Other Operating Expenses
0
0
(78)
0
16
0
0
0
(333)
(379)
(380)
0
3
0
0
0
(299)
(3)
0
0
(1 693)
(1 702)
(1 693)
0
0
0
0
0
(617)
0
(1 283)
0
0
0
(1 337)
0
(8 431)
0
(8 514)
0
0
Operating Income
189
N/A
803
+325%
(997)
N/A
111
N/A
1 913
+1 623%
2 725
+42%
386
-86%
2 963
+668%
838
-72%
(684)
N/A
2 712
N/A
(2 636)
N/A
(5 543)
-110%
(5 618)
-1%
(11 735)
-109%
(14 057)
-20%
(10 227)
+27%
(10 723)
-5%
(6 463)
+40%
(5 857)
+9%
(9 286)
-59%
(9 562)
-3%
(9 500)
+1%
(4 020)
+58%
(5 877)
-46%
(4 853)
+17%
(5 400)
-11%
(5 877)
-9%
(4 055)
+31%
(4 357)
-7%
(6 794)
-56%
(2 938)
+57%
5 235
N/A
10 156
+94%
12 291
+21%
11 230
-9%
(6 310)
N/A
(177)
+97%
(11 438)
-6 354%
(4 578)
+60%
(5 062)
-11%
Pre-Tax Income
Interest Income Expense
3
539
(6)
646
750
177
(150)
578
438
1 118
1 685
(881)
(544)
(1 576)
(2 334)
(8 957)
(9 931)
(10 676)
(11 511)
601
332
(1 125)
(1 439)
(7 613)
(7 646)
(21 502)
(20 090)
(18 442)
(16 076)
(1 326)
(4 076)
(2 685)
(5 395)
(3 964)
(1 212)
(2 034)
(1 890)
(2 025)
(1 980)
(1 949)
(1 952)
Non-Reccuring Items
(78)
(78)
0
0
0
63
65
(328)
0
0
0
0
(2)
(104)
(199)
(307)
0
(185)
(99)
(1 700)
0
0
0
(1 397)
(1 953)
(1 882)
(1 882)
(1 172)
0
(1 282)
0
(1 932)
(1 932)
(1 337)
0
(8 431)
0
(8 514)
0
(9 411)
(8 456)
Gain/Loss on Disposition of Assets
2
11
18
37
54
0
0
5
0
548
550
576
576
40
48
60
65
7
0
(16)
(42)
(21)
48
(7)
2 466
2 469
2 390
2 444
(1)
(2)
10
1
1
(47)
(49)
(41)
(42)
245
250
265
273
Total Other Income
123
(820)
(771)
(815)
(816)
164
55
(44)
(117)
(142)
(256)
(40)
(155)
(341)
(171)
63
112
318
281
124
97
74
103
(10)
(15)
81
160
309
359
300
219
(133)
(134)
(145)
(298)
(525)
(492)
(491)
(373)
(41)
(68)
Pre-Tax Income
237
N/A
454
+92%
(1 757)
N/A
(22)
+99%
1 901
N/A
3 129
+65%
356
-89%
3 174
+792%
1 159
-63%
839
-28%
4 691
+459%
(2 980)
N/A
(5 669)
-90%
(7 599)
-34%
(14 391)
-89%
(23 197)
-61%
(19 981)
+14%
(21 260)
-6%
(17 792)
+16%
(6 848)
+62%
(8 898)
-30%
(10 633)
-19%
(10 788)
-1%
(13 048)
-21%
(13 026)
+0%
(25 689)
-97%
(24 824)
+3%
(22 738)
+8%
(19 774)
+13%
(6 667)
+66%
(10 641)
-60%
(7 687)
+28%
(2 225)
+71%
4 663
N/A
10 731
+130%
199
-98%
(8 734)
N/A
(10 961)
-25%
(13 541)
-24%
(15 715)
-16%
(15 264)
+3%
Net Income
Tax Provision
(962)
(4 064)
(3 446)
(3 530)
(3 413)
(489)
144
(457)
0
(194)
(894)
241
956
2 217
3 712
2 495
1 040
802
(534)
(2 215)
(1 547)
(3 296)
(4 885)
(717)
(904)
287
1 767
(130)
(266)
(119)
(27)
(292)
(375)
(914)
(1 047)
4 504
6 200
5 769
6 116
127
1 104
Income from Continuing Operations
(726)
(3 611)
(5 203)
(3 552)
(1 511)
2 640
499
2 717
1 157
644
3 796
(2 739)
(4 713)
(5 382)
(10 679)
(20 702)
(18 939)
(20 457)
(18 325)
(9 063)
(10 447)
(13 930)
(15 674)
(13 765)
(13 929)
(25 401)
(23 056)
(22 868)
(20 041)
(6 787)
(10 669)
(7 978)
(2 601)
3 749
9 685
4 704
(2 535)
(5 193)
(7 425)
(15 588)
(14 161)
Income to Minority Interest
8
3
15
50
72
71
59
24
0
0
0
0
0
0
0
4
6
22
8
2
7
(17)
(7)
26
923
1 668
2 323
3 411
2 996
2 411
1 827
660
256
241
387
0
825
0
0
0
0
Net Income (Common)
(790)
N/A
(3 679)
-366%
(5 259)
-43%
(3 502)
+33%
(1 439)
+59%
2 711
N/A
558
-79%
2 740
+391%
1 157
-58%
644
-44%
3 796
+489%
(2 739)
N/A
(4 713)
-72%
(5 382)
-14%
(10 679)
-98%
(20 698)
-94%
(18 933)
+9%
(20 435)
-8%
(18 317)
+10%
(9 061)
+51%
(10 439)
-15%
(13 947)
-34%
(15 681)
-12%
(13 739)
+12%
(13 007)
+5%
(23 733)
-82%
(20 733)
+13%
(19 458)
+6%
(17 045)
+12%
(4 375)
+74%
(8 842)
-102%
(7 318)
+17%
(2 345)
+68%
3 990
N/A
10 072
+152%
4 704
-53%
(1 709)
N/A
(4 506)
-164%
(6 951)
-54%
(15 588)
-124%
(14 161)
+9%
EPS (Diluted)
-46.47
N/A
-216.41
-366%
-309.35
-43%
-206
+33%
-84.64
+59%
159.47
N/A
32.82
-79%
161.17
+391%
68.05
-58%
37.88
-44%
223.29
+489%
-161.11
N/A
-277.23
-72%
-316.58
-14%
-628.17
-98%
-1 217.52
-94%
-1 113.7
+9%
-1 202.05
-8%
-1 077.47
+10%
-503.38
+53%
-549.42
-9%
-734.05
-34%
-825.31
-12%
-723.1
+12%
-684.57
+5%
-1 249.1
-82%
-987.28
+21%
-972.9
+1%
-811.66
+17%
-195.56
+76%
-394.38
-102%
-329.29
+17%
-99.62
+70%
166.86
N/A
421.26
+152%
197.49
-53%
-71.49
N/A
-188.44
-164%
-290.71
-54%
-651.97
-124%
-592.28
+9%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.